Another advantage of our in vivo model was that despite permanent FGF1 expression in EC, transgenic animals exhibited a normal phenotype, including unperturbed kidney structure; therefore, we were able to specifically focus on FGF-dependent events caused by ischemia and postischemic stress. The gene discussed is FGF1; the disease is ischemia.